Dr. Silver is a partner at Brunswick Group, an advisory firm specializing in critical issues and corporate relations, where she is co-leading the firm’s global pharmaceutical and healthcare offering. Prior to joining Brunswick, she was an executive at GE Healthcare’s Operating Room Solutions business, a new division at GE Healthcare. Prior to this, she was Global Head of Neuroscience/General Medicine Strategic Marketing at GE. In this role, she developed the disease-focused growth strategy across the diagnostics and imaging portfolio. Earlier in her career, she was the director of the CNS Franchise of Eisai Ltd., UK for which she was responsible for growth and profitability of key brands in the UK including Aricept® and Zonegran®. Prior to her tenure at Eisai, she was Therapeutic Area Director of Neuroscience at Bristol-Myers Squibb UK. Dr. Silver received her BS from the University of Bristol and her medical degree from the University of London. She is also a Fellow of the Faculty of Pharmaceutical Medicine in the UK.